Mahvash Disease: An Autosomal Recessive Hereditary Pancreatic Neuroendocrine Tumor Syndrome
- 27 July 2016
- journal article
- Published by Taylor & Francis in International Journal of Endocrine Oncology
- Vol. 3 (3), 235-243
- https://doi.org/10.2217/ije-2016-0005
Abstract
Mahvash disease is a rare autosomal recessive hereditary pancreatic neuroendocrine tumor syndrome characterized by inactivating mutations in the glucagon receptor, hyperglucagonemia without symptoms of the glucagonoma syndrome, pancreatic α-cell hyperplasia and pancreatic neuroendocrine tumors. In Mahvash disease, the lack of negative feedback from glucagon receptor signaling results in compensatory hyperplasia of pancreatic α-cells and secondary tumorigenesis. Over ten clinical cases consistent with Mahvash disease have been reported thus far, most of which have confirmed biallelic mutations in the glucagon receptor. Mahvash disease provides insight into glucagon signaling pathway regulation and pathogenesis of pancreatic neuroendocrine tumors.Keywords
This publication has 45 references indexed in Scilit:
- Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor MutationsJournal of Clinical Endocrinology & Metabolism, 2015
- Pancreatic α-Cell Hyperplasia: Facts and MythsJournal of Clinical Endocrinology & Metabolism, 2014
- Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperonesJournal of Molecular Endocrinology, 2012
- An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: Characteristic features on computed tomographyClinics and Research in Hepatology and Gastroenterology, 2012
- A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signalingEndocrinología y Nutrición, 2011
- Pathologic pancreatic endocrine cell hyperplasiaWorld Journal of Gastroenterology, 2011
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell TumorPancreas, 2009
- Glucagon Cell Adenomatosis: A Newly Recognized Disease of the Endocrine PancreasJournal of Clinical Endocrinology & Metabolism, 2009
- Nesidioblastosis and Hyperplasia of α Cells, Microglucagonoma, and Nonfunctioning Islet Cell Tumor of the PancreasPancreas, 2008
- The Glucagonoma Syndrome Clinical and Pathologic Features in 21 PatientsMedicine, 1996